Silvitra: Dual-Action Erectile Dysfunction and Premature Ejaculation Relief

Silvitra

Silvitra

Silvitra is a highly effective drug used in treatment of erectile dysfunction. Silvitra is a new ED drug combining sildenafil citrate (Viagra) and vardenafil (Levitra) in one tablet.
Product dosage: 120mg
Package (num)Per pillPriceBuy
30$3.20$96.00 (0%)🛒 Add to cart
60$2.93$192.00 $176.00 (8%)🛒 Add to cart
90$2.86$288.00 $257.00 (11%)🛒 Add to cart
120$2.81$384.00 $337.00 (12%)🛒 Add to cart
180
$2.77 Best per pill
$576.00 $498.00 (14%)🛒 Add to cart

Similar products

Silvitra is a combination pharmaceutical agent designed to address two of the most prevalent male sexual health concerns: erectile dysfunction and premature ejaculation. It synergistically combines Sildenafil Citrate, a PDE5 inhibitor, and Dapoxetine, a selective serotonin reuptake inhibitor, to provide a comprehensive treatment approach. This dual-mechanism therapy is prescribed for men seeking to improve both the rigidity and duration of erection, thereby enhancing sexual performance and confidence. Its formulation is backed by clinical evidence supporting efficacy in improving control over ejaculation and achieving satisfactory erections. Treatment is intended for use under medical supervision as part of a managed therapeutic plan.

Features

  • Active ingredients: Sildenafil Citrate (100mg) and Dapoxetine HCl (60mg)
  • Pharmaceutical class: PDE5 inhibitor and SSRI combination
  • Administration: Oral tablet
  • Onset of action: Approximately 30-60 minutes post-ingestion
  • Duration of effect: Sildenafil effects last up to 4-6 hours; Dapoxetine effects are acute around time of sexual activity
  • Available by prescription only

Benefits

  • Achieves and maintains firmer erections sufficient for sexual intercourse
  • Significantly delays ejaculation, improving intravaginal ejaculatory latency time
  • Enhances sexual confidence and reduces performance-related anxiety
  • Addresses two common sexual dysfunctions with a single tablet
  • Allows for more spontaneous sexual activity compared to some mono-therapies
  • Supported by clinical data demonstrating improved sexual satisfaction scores

Common use

Silvitra is indicated for the treatment of adult men with erectile dysfunction (ED) concomitant with premature ejaculation (PE). It is suitable for patients who have been diagnosed with both conditions and for whom combination therapy is deemed appropriate. It is not intended for use in men without these diagnosed conditions, in women, or in individuals under 18 years of age. Sexual stimulation is required for the erectile response to occur.

Dosage and direction

The recommended dose is one tablet taken approximately 1 to 3 hours prior to anticipated sexual activity. It should be swallowed whole with a full glass of water; do not crush, split, or chew the tablet. It may be taken with or without food, though a high-fat meal may delay the onset of action. Do not take more than one tablet within a 24-hour period. The dosing should be adjusted based on individual efficacy and tolerability, under a physician’s guidance.

Precautions

Prior to initiating treatment, a thorough medical evaluation should be conducted to assess cardiovascular status, as sexual activity carries potential cardiac risk. Use with caution in patients with anatomical deformation of the penis, bleeding disorders, or active peptic ulceration. Avoid excessive alcohol consumption, as it may increase the risk of orthostatic hypotension and decrease sexual performance. Not recommended for use with other treatments for erectile dysfunction or premature ejaculation.

Contraindications

Hypersensitivity to Sildenafil Citrate, Dapoxetine, or any excipients. Concomitant administration with nitrates or nitric oxide donors in any form. Patients with severe hepatic impairment, severe cardiovascular disorders, unstable angina, or a history of recent stroke or myocardial infarction. Concomitant use with potent CYP3A4 inhibitors or monoamine oxidase inhibitors. History of non-arteritic anterior ischemic optic neuropathy.

Possible side effects

Common adverse reactions may include headache, flushing, dizziness, nasal congestion, dyspepsia, nausea, and insomnia. Visual disturbances (such as blurred vision, color tinge) and hypotension may occur. Less frequently, palpitations, tachycardia, dry mouth, and diarrhea have been reported. In rare instances, priapism (prolonged and painful erection) requires immediate medical attention to avoid permanent damage.

Drug interaction

Contraindicated with nitrates, recreational drugs containing nitrites, and potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir). Caution with alpha-blockers, antihypertensives, and moderate CYP3A4 inhibitors. Dapoxetine may interact with serotonergic drugs (e.g., SSRIs, SNRIs, triptans) increasing risk of serotonin syndrome. Avoid with other PDE5 inhibitors. Inform your physician of all concomitant medications, including over-the-counter drugs and herbal supplements.

Missed dose

Silvitra is taken on an as-needed basis; there is no daily dosing schedule. If a dose is missed, it is not to be made up. Do not take an extra tablet to compensate for a missed dose. Take the next tablet as planned prior to your next anticipated sexual activity, ensuring at least 24 hours have passed since the last dose.

Overdose

In case of suspected overdose, seek immediate medical attention. Symptoms may include severe hypotension, syncope, prolonged erection, vertigo, and gastrointestinal disturbances. Standard supportive measures should be employed; haemodialysis is not expected to accelerate clearance. Management of priapism may require intracavernosal intervention.

Storage

Store at room temperature (15-30°C), in the original packaging, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Do not dispose of medication in wastewater or household waste; return unused or expired product to a pharmacy for proper disposal.

Disclaimer

This information is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized medical guidance. Do not initiate, alter, or discontinue treatment without consulting your physician. The manufacturer is not liable for any incorrect use or self-diagnosis.

Reviews

“After struggling with both ED and PE for years, Silvitra has been a game-changer. The combined effect allows for confidence and performance I hadn’t experienced in a long time.” – Patient, 48 “As a urologist, I find Silvitra a valuable option for appropriately selected patients. The dual action addresses common comorbidities effectively, though patient counseling on expectations and side effects is essential.” – Dr. Evans, MD “Noticeable improvement in control and sustainability. Mild headache initially but subsided after the first few uses.” – Patient, 52 “Effective, but must be timed correctly. Taking it about 90 minutes before activity works best for me.” – Patient, 45